One-two punch catches cancer cells in vulnerable state

Timing may be decisive when it comes to overcoming cancer’s ability to evade treatment. By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women’s Hospital were able to target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking tumors in the lab and in pre-clinical models. The team reports its findings in Nature Communications on Feb. 11. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *